What Regulatory Executives Think about Outsourcing

In the first quarter of 2013, Optum Life Sciences surveyed 46 small, mid-size and large life science companies to gauge their regulatory outsourcing practices and plans. Companies represented a range of therapeutic areas — predominantly oncology, CNS, GI, CV and respiratory.

View the infographic to take a closer look at their regulatory outsourcing activities.